Hyperhidrosis is a condition that causes excessive sweating. The word “hyperhidrosis” translates to – too much (hyper) sweating (hidrosis). Many people who have hyperhidrosis sweat from one or two areas of the body while the rest of the body remains dry. Hyperhidrosis is divided into two categories i.e. Primary Focal and Secondary Generalized,
As per the National Organization of Rare Disorders (NORD), “Primary hyperhidrosis is a rare disorder characterized by excessive sweating on the palms of the hands, the soles of the feet, in the armpits (axillary), in the groin area, and/or under the breasts. When excessive sweating occurs as part of some other disorder, it is said to be secondary hyperhidrosis, which is a more commonly encountered condition than is primary hyperhidrosis.”
The treatment for axillary hyperhidrosis involves clinical treatment, non-surgical procedures, and a surgical approach. However, the choice of treatment depends on severity and affordability, as majority of treatment do not involve reimbursement except surgical treatment.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-market
The Axillary Hyperhidrosis market report also covers emerging drugs, current treatment practices, Axillary Hyperhidrosis market share of the individual therapies, current and forecasted Axillary Hyperhidrosis Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Axillary Hyperhidrosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Axillary Hyperhidrosis Market Key Facts
-
As per the Archives of Dermatological Research (2016), the prevalence of hyperhidrosis in the United States was reported to be 4.8%, representing approximately 15.3 million people
-
As per the study conducted by Jacob. 2018, titled “Examining Hyperhidrosis: An Update on New Treatments,” about 90% of hyperhidrosis cases are primary and affect the axillae.
-
According to the estimates, Axillary Hyperhidrosis affects males and females in equal numbers.
-
As per Strutton et al., (n.d.), the prevalence of hyperhidrosis was 2.9%. Out of the total cases, 50.8% of this population reported that they have axillary hyperhidrosis.
Key Benefits of Axillary Hyperhidrosis Market Report
-
Axillary Hyperhidrosis market report provides an in-depth analysis of Axillary Hyperhidrosis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
-
The Axillary Hyperhidrosis market report will help in developing business strategies by understanding the Axillary Hyperhidrosis Market trends & developments, key players, and future market competition that will shape and drive the Axillary Hyperhidrosis market in the upcoming years.
-
The Axillary Hyperhidrosis market report covers Axillary Hyperhidrosis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Axillary Hyperhidrosis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
The Axillary Hyperhidrosis market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Axillary Hyperhidrosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Axillary Hyperhidrosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Axillary Hyperhidrosis Epidemiology
The Axillary Hyperhidrosis epidemiology section covers insights about the historical and current Axillary Hyperhidrosis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Axillary Hyperhidrosis Drugs Uptake and Key Market Players
The Axillary Hyperhidrosis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Axillary Hyperhidrosis market or expected to get launched in the market during the study period. The analysis covers Axillary Hyperhidrosis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years.
Some of the key companies in the Axillary Hyperhidrosis market include:
Brickell Bio
Allergan
Dr. August Wolff GmbH
And others.
Axillary Hyperhidrosis Therapies covered in the report include:
WO3970
Sofpironium Bromide Gel
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Axillary Hyperhidrosis Competitive Intelligence Analysis
4. Axillary Hyperhidrosis Market Overview at a Glance
5. Axillary Hyperhidrosis Disease Background and Overview
6. Axillary Hyperhidrosis Patient Journey
7. Axillary Hyperhidrosis Epidemiology and Patient Population
8. Axillary Hyperhidrosis Treatment Algorithm, Current Treatment, and Medical Practices
9. Axillary Hyperhidrosis Unmet Needs
10. Key Endpoints of Axillary Hyperhidrosis Treatment
11. Axillary Hyperhidrosis Marketed Products
12. Axillary Hyperhidrosis Emerging Therapies
13. Axillary Hyperhidrosis Seven Major Market Analysis
14. Attribute Analysis
15. Axillary Hyperhidrosis Market Outlook (7 major markets)
16. Axillary Hyperhidrosis Access and Reimbursement Overview
17. KOL Views on the Axillary Hyperhidrosis Market.
18. Axillary Hyperhidrosis Market Drivers
19. Axillary Hyperhidrosis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-market
Latest Reports By DelveInsight
Axillary Hyperhidrosis Pipeline Insights
“Axillary Hyperhidrosis Pipeline Insight, 2021” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Axillary Hyperhidrosis market.
Tenosynovitis Market Insight
DelveInsight’ s “Tenosynovitis Market Insights, Epidemiology, and Market Forecast 2030” report provide a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Tenosynovitis market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/